insulin resistance glp 1 Your Body Isn't Broken: How GLP-1 Medications Are Changing The Game For PCOS Dr. - There remains confusion

S.HueyE

For patients who are hesitant about injections, the convenience of a daily pill lowers barriers to starting and staying on the medication long-term

doi: 10.1056/NEJMoa2306963 [DOI] [PubMed] [Google Scholar] 65

39 In the SCALE trial, which enrolled 3,731 overweight or obese adults, liraglutide 3.0 mg daily was shown to reduce both systolic and diastolic BP, with average delta of 2.8 mmHg (95% CI [3.56, 2.09) and 0.9 mmHg (95% CI [1.41, 0.37), respectively

Data on the effects of GLP-1 receptor agonists have been published in patients with COPD, while no data on GIP/GLP-1 receptor agonists have been found

To explore these long-term tolerability differences in detail, see Safety and Tolerability of GLP-1 Receptor Agonists